“Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies” (2020) SKIN The Journal of Cutaneous Medicine, 4(6), p. s95. doi:10.25251/skin.4.supp.95.